Millicom (Tigo) share repurchase activity
May 17, 2024 17:30 ET
|
Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, May 17, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 36,701 of its Swedish Depository...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 17, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
May 17, 2024 17:00 ET
|
Achilles Therapeutics PLC
LONDON, May 17, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal...
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
May 17, 2024 17:00 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., May 17, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Plus Therapeutics Announces New Employment Inducement Grants
May 17, 2024 17:00 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
May 17, 2024 16:33 ET
|
BriaCell Therapeutics Corp.
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
DBV Technologies annonce son intention de modifier le ratio d'ADS
May 17, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 17 mai 2024 DBV Technologies annonce son intention de modifier le ratio d'ADS DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP:...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Filing
May 17, 2024 16:30 ET
|
Nvni Group Limited
Nvni Group Limited announced that it received a notice from Nasdaq indicating the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1).
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing
May 17, 2024 16:30 ET
|
DZS
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing